"paper"

Genomic evidence for reinfection with SARS-CoV-2: a case study

Remdesivir for the Treatment of Covid-19 — Final Report

Fellow: Nicolas Jean Dubuisson, Belgium Term of the Fellowship: March – September 2019 Hosting department: Department of Neurology and Neurosurgery, Neuromuscular Disorders, University Medical Center (UMC) Utrecht, The Netherlands Supervisor: Dr. H.S. Goedee, PhD These 6 weeks in Utrecht were… Continue Reading

EJoN publishes EAN consensus statement for management of patients with neurological diseases during the COVID‐19 pandemic

Newest addition to Breaking News submitted by Neurooncology Panel: Neuro-oncology Management During the COVID-19 Pandemic With a Focus on WHO Grade III and IV Gliomas

Clinical and neuroimaging correlation in patients with COVID-19

Risk factors for intracerebral hemorrhage in patients with COVID‐19

Multiple sclerosis and COVID‐19: how many are at risk?

Thrombolysis and bridging therapy in patients with acute ischemic stroke and Covid‐19

Increased risk of acute stroke among patients with severe COVID‐19: a multicenter study and meta‐analysis

Clustering and superspreading potential of SARS-CoV-2 infections in Hong Kong

Auto-antibodies against type I IFNs in patients with life-threatening COVID-19

Humoral Immune Response to SARS-CoV-2 in Iceland

Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'

Written by Kate Boor Ellis On 21 September 2020, Alzheimer Europe marked World Alzheimer’s Day with a social media campaign, calling attention to the damage COVID-19 is doing to the field of dementia research, together with a call for urgent… Continue Reading